Uptake of irinotecan metabolite SN-38 by the human intestinal cell line Caco-2

被引:25
|
作者
Itoh, T
Itagaki, S
Sumi, Y
Hirano, T
Takemoto, I
Iseki, K
机构
[1] Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Clin Pharmaceut & Therapeut, Kita Ku, Sapporo, Hokkaido 0600812, Japan
[2] Sapporo Social Insurance Gen Hosp, Dept Pharm, Atsubetsu Ku, Sapporo, Hokkaido 0048618, Japan
关键词
irinotecan; diarrhea; Caco-2; cells; baicalin;
D O I
10.1007/s00280-004-0937-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: The aim of this study was to investigate the transport mechanisms of transporters that contribute to the intestinal uptake of 7-ethyl-10-hydroxycamptothecin (SN-38). Methods: Human intestinal epithelial Caco-2 cells were used to investigate the mechanistic basis of transepithelial uptake of SN-38. We investigated the characteristics of SN-38 uptake into Caco-2 cells. The effects of baicalin and sulfobromophthalein (BSP) on the uptake of SN-38 by Caco-2 cells were examined. Results: Uptake of SN-38 was significantly reduced at 4 degrees C. Baicalin inhibited the uptake of SN-38 in a concentration-dependent manner. BSP significantly reduced the uptake of SN-38. However, probenecid, pravastatin and grepafloxacin did not affect the uptake of SN-38. Conclusions: The results suggest that a specific transport system mediates the uptake of SN-38 across the apical membrane in Caco-2 cells.
引用
收藏
页码:420 / 424
页数:5
相关论文
共 50 条
  • [21] Cellular uptake and toxicity of irinotecan and its active metabolite, SN-38 in hamster intestine and human colon cancer cells
    Matsuzaki, Y
    Kobayashi, K
    Bouscarel, B
    Ceryak, S
    Jordan, T
    Fromm, H
    Kudoh, S
    Tanaka, N
    GASTROENTEROLOGY, 1999, 116 (04) : A906 - A906
  • [22] Effects of capsaicin on human intestinal cell line Caco-2
    Isoda, H
    Han, JY
    Tominaga, M
    Maekawa, T
    CYTOTECHNOLOGY, 2001, 36 (1-3) : 155 - 161
  • [23] Effects of capsaicin on human intestinal cell line Caco-2
    Hiroko Isoda
    Junkyu Han
    Makoto Tominaga
    Takaaki Maekawa
    Cytotechnology, 2001, 36 : 155 - 161
  • [24] Effect of insulin on cephalexin uptake and transepithelial transport in the human intestinal cell line Caco-2
    Watanabe, K
    Terada, K
    Jinriki, T
    Sato, J
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2004, 21 (01) : 87 - 95
  • [25] Effect of Tacrolimus on the Pharmacokinetics and Glucuronidation of SN-38, an Active Metabolite of Irinotecan
    Tanaka, Yoshiteru
    Katoh, Miki
    Fujioka, Miho
    Onishi, Katsuhiro
    Sakakibara, Yukiko
    Hasegawa, Takaaki
    Nadai, Masayuki
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2013, 133 (04): : 463 - 471
  • [26] Impact of obesity on accumulation of the toxic irinotecan metabolite, SN-38, in mice
    Mallick, Pankajini
    Shah, Pranav
    Gandhi, Adarsh
    Ghose, Romi
    LIFE SCIENCES, 2015, 139 : 132 - 138
  • [27] In vitro conversion of irinotecan to SN-38 in human plasma
    Shingyoji, M
    Takiguchi, Y
    Watanabe-Uruma, R
    Asaka-Amano, Y
    Matsubara, H
    Kurosu, K
    Kasahara, Y
    Tanabe, N
    Tatsumi, K
    Kuriyama, T
    CANCER SCIENCE, 2004, 95 (06): : 537 - 540
  • [28] Transport Characteristics of Candesartan in Human Intestinal Caco-2 Cell Line
    Zhou, Lingjie
    Chen, Xiaoping
    Gu, Yuanqing
    Liang, Jianying
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2009, 30 (05) : 259 - 264
  • [29] UPTAKE OF THE CEPHALOSPORIN, CEPHALEXIN, BY A DIPEPTIDE TRANSPORT CARRIER IN THE HUMAN INTESTINAL-CELL LINE, CACO-2
    DANTZIG, AH
    BERGIN, L
    BIOCHIMICA ET BIOPHYSICA ACTA, 1990, 1027 (03) : 211 - 217
  • [30] Extracellular ATP hydrolysis in Caco-2 human intestinal cell line
    Schachter, J.
    Alvarez, C. L.
    Bazzi, Z.
    Faillace, M. P.
    Corradi, G.
    Hattab, C.
    Rinaldi, D. E.
    Gonzalez-Lebrero, R.
    Pucci Molineris, M.
    Sevigny, J.
    Ostuni, M. A.
    Schwarzbaum, P. J.
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2021, 1863 (10):